In the present study, NOTCH1 mutation promoted the migration and invasion of ovarian cancer cells in vitro and in vivo, and these effects could be attenuated by NOTCH1 inhibitor (LY3039478) treatment, especially in cells with NOTCH1 mutation. Here, NOTCH1 is linked to ovarian carcinoma.